Key Highlights

Risk & Performance

Pipeline Risk Assessment

Pipeline Risk Assessment

Based on historical performance

Moderate Risk

Score: 45/100

Failure Rate

0.0%

0 terminated/withdrawn out of 4 trials

Success Rate

100.0%

+13.5% vs industry average

Late-Stage Pipeline

0%

0 trials in Phase 3/4

Results Transparency

0%

0 of 1 completed trials have results

Key Signals

2 recruiting

Enrollment Performance

Analytics

Phase 2
1(50.0%)
N/A
1(50.0%)
2Total
Phase 2(1)
N/A(1)

Activity Timeline

Global Presence

Loading network data...

Clinical Trials (4)

Showing 4 of 4 trials
NCT07430046Phase 2Recruiting

Repurposing Mirtazapine in Rett Syndrome

Role: collaborator

NCT01272154Not ApplicableCompleted

Cerebellum and Cortical Plasticity: the Case of Dystonia

Role: collaborator

NCT07126353Not Yet Recruiting

Metabolic Risk Assessment in Prepubertal Children With Congenital Hypothyroidism

Role: collaborator

NCT06884631Recruiting

Metabolic Exercise Test Data Combined with Cardiac and Kidney Indexes (MECKI) Score Evolution: Identification of Cardiovascular Risk in Patients with Heart Failure

Role: collaborator

All 4 trials loaded